Physician profile
Michael Graham
NPI 1083776868
$5,306.93
in general payments reported to CMS, 2019-2025
36 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $699 · 2020: $609 · 2021: $1,138 · 2022: $1,363 · 2023: $1,247 · 2024: $136 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,002.68 | 2019-2023 | |
| Intuitive Surgical, INC. | $470.75 | 2019-2023 | Da Vinci Surgical System |
| Exeltis, USA INC. | $395.13 | 2020-2023 | Slynd |
| Mayne Pharma Commercial LLC | $386.29 | 2021-2024 | |
| Pfizer INC. | $328.05 | 2019-2023 | |
| Astellas Pharma US INC | $302.13 | 2023-2025 | Veozah, Myrbetriq |
| Amgen INC. | $282.70 | 2021-2023 | Evenity, Prolia |
| Biohaven Pharmaceuticals, INC. | $263.49 | 2020-2021 | |
| Hologic Sales and Service, LLC | $168.92 | 2020-2025 | Aptima |
| Organon LLC | $160.94 | 2021-2024 | Nexplanon |
| Therapeuticsmd, INC. | $150.16 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $130.56 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $119.81 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $105.72 | 2019-2021 | |
| Asensus Surgical, INC. | $100.00 | 2023 | Senhance |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $99.81 | 2020-2023 | Balcoltra |
| Sumitomo Pharma America, INC. | $96.36 | 2023 | Myfembree |
| Biom'Up France Sas | $89.30 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.24 | 2019-2022 | |
| Scynexis, INC. | $76.55 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $72.70 | 2020-2021 | |
| Evofem Biosciences, INC. | $72.65 | 2021-2024 | |
| Applied Medical Resources Corporation | $72.22 | 2021 | |
| Millicent US INC | $47.91 | 2020-2024 | Intrarosa, Femring |
| Stryker Corporation | $32.08 | 2023 | 1788 |
| Minerva Surgical, INC | $25.61 | 2020-2021 | |
| Inari Medical, INC. | $25.39 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Mycovia Pharmaceuticals, INC. | $24.69 | 2023 | Vivjoa |
| Novo Nordisk INC | $18.90 | 2019 | |
| Coloplast Corp | $17.21 | 2023 | Altis |
| Sage Therapeutics, LLC | $16.86 | 2020 | |
| Allergan, INC. | $14.97 | 2020 | |
| Myovant Sciences INC. | $14.72 | 2022 | |
| Ibsa Pharma INC. | $14.08 | 2023 | Tirosint, Licart |
| Coopersurgical, INC. | $13.35 | 2022 | |
| Collegium Pharmaceutical, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.